ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,117Medicare Part D Prescriptions Filled, Including Refills

Rank: 96 out of 1262

$412K Total Retail Price of All Prescriptions

Rank: 290 out of 1262

327 Patients Receiving at Least One Drug in Part D
78% Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Florida
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

10% of this provider’s 327 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 327 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $101 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Florida
FUROSEMIDE 328 240 49 1 10
TRAZODONE HCL 236 164 45 2 42
METFORMIN HCL 221 146 39 3 13
GLIPIZIDE 215 152 32 4 73
LEVOTHYROXINE SODIUM 210 172 27 5 3
LORAZEPAM 195 167 35 B 6 39
TRAMADOL HCL 186 119 50 7 20
CLOPIDOGREL 171 112 26 8 11
GABAPENTIN 166 68 23 9 7
AMLODIPINE BESYLATE 150 122 26 10 4
METOPROLOL TARTRATE 148 131 30 11 9
RANITIDINE HCL 143 64 24 12 51
ALPRAZOLAM 143 99 27 B 12 8
HYDROCHLOROTHIAZIDE 133 118 29 14 25
LOVASTATIN 125 72 24 15 64
SIMVASTATIN 125 106 24 15 2
BUSPIRONE HCL 123 96 29 17 173
ATENOLOL 122 94 22 18 26
TEMAZEPAM 117 79 27 B 19 28
LISINOPRIL 106 82 21 20 6
AMOXICILLIN 102 61 58 21 199
OMEPRAZOLE 100 71 32 22 1
QUETIAPINE FUMARATE 93 88* 17 A 23 50
ENALAPRIL MALEATE 85 48 11 24 77
ZOLPIDEM TARTRATE 84 59 14 25 27
ALLOPURINOL 83 83 13 26 65
CARVEDILOL 78 52 15 27 17
GLYBURIDE 73 59 14 R 28 163
TAMSULOSIN HCL 73 73 13 28 14
IBUPROFEN 72 54 26 30 74
BENZTROPINE MESYLATE 72 <11 <11 R 30 108
ALENDRONATE SODIUM 70 65* 12 32 53
CITALOPRAM HBR 70 55 16 32 35
DIVALPROEX SODIUM 70 <11 <11 32 114
NOVOLOG MIX 70-30 FLEXPEN 69 <11 <11 35 215
ACETAMINOPHEN-CODEINE 68 24 11 S3 36 140
DOXAZOSIN MESYLATE 67 62* 11 37 79
FAMOTIDINE* 66 <11 <11 38 123
RENVELA 66 <11 <11 38 125
NOVOLIN 70-30 64 <11 <11 40 245
PREDNISONE 64 45 46 40 21
ATORVASTATIN CALCIUM 63 <11 <11 42 12
CLONAZEPAM 58 <11 <11 B 43 23
HYDRALAZINE HCL 58 <11 <11 43 116
TRIAMCINOLONE ACETONIDE 57 31 18 45 96
CLOTRIMAZOLE-BETAMETHASONE 54 38 16 46 134
HYDROCODONE-ACETAMINOPHEN 53 <11 <11 S3 47 5
SERTRALINE HCL 52 <11 <11 48 36
OXYCODONE-ACETAMINOPHEN 52 13 14 S2 48 58
POTASSIUM CHLORIDE 51 46* 11 50 38
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.